Evolut™ EXPAND TAVR II Pivotal Trial

NCT ID: NCT05149755

Last Updated: 2025-12-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

650 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-27

Study Completion Date

2034-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Multi-center, international, prospective, randomized study. Subjects will be randomized to either transcatheter aortic valve replacement (TAVR) with the Evolut PRO+ TAVR System, or Evolut FX System, and guideline-directed management (GDMT) or GDMT alone.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Moderate Aortic Valve Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Medtronic Evolut PRO+, or Evolut FX,TAVR System, & guideline-directed management & therapy (GDMT)

Medtronic Evolut PRO+ TAVR or Evolut FX TAVR Systems, \& guideline-directed management \& therapy

Group Type EXPERIMENTAL

Medtronic Evolut PRO+ TAVR System, or Evolut FX TAVR System, and guideline-directed management and therapy (GDMT)

Intervention Type DEVICE

Patients will have a Transcatheter Aortic Valve Replacement (TAVR) with either an Evolut PRO+ TAVR, or Evolut FX TAVR, heart valve, and given clinical site-determined guideline-directed management and therapy (GDMT).

Clinical site determined guideline-directed management and therapy (GDMT) alone

Clinical site determined guideline-directed management and therapy (GDMT) alone

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Medtronic Evolut PRO+ TAVR System, or Evolut FX TAVR System, and guideline-directed management and therapy (GDMT)

Patients will have a Transcatheter Aortic Valve Replacement (TAVR) with either an Evolut PRO+ TAVR, or Evolut FX TAVR, heart valve, and given clinical site-determined guideline-directed management and therapy (GDMT).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

o Moderate AS, defined as follows by transthoracic echo (TTE) as assessed by the ECL:

* AVA \>1.0 cm² and \<1.5cm²; or
* AVA ≤ 1.0 cm² with AVAI \> 0.6cm²/m² if BMI \< 30 kg/m²: or
* AVA ≤ 1.0 cm² with AVAI \> 0.5cm²/m² if BMI ≥ 30 kg/m²:

and

* Max aortic velocity ≥ 3.0 m/sec. and \< 4.0 m/sec. or
* Mean aortic gradient ≥ 20mmHg and \< 40.0 mmHg

Any of the following at-risk features:

* Symptoms of AS, defined as:
* NYHA ≥ Class II, or
* Reduced functional capacity, defined as

* 6MWT \< 300 meters, or
* \< 85% of age-sex predicted METs on exercise tolerance testing (ETT)
* Documented heart failure event or hospitalization for heart failure within 1 calendar year prior to consent
* NT-proBNP ≥ 600 pg/ml (or BNP ≥ 80 pg/ml), or
* Persistent AF or Paroxysmal AF episode within 6 months prior to consent, or
* Elevated aortic valve calcium score (\>1200 AU for females and \> 2000 AU for males) as assessed by the MDCT core lab, or
* Any of the following by the qualifying TTE as assessed by the ECL:

* Global longitudinal strain ≤16% (absolute value), or
* E/e' ≥ 14.0 (average of medial and lateral velocities), or
* Diastolic dysfunction ≥ Grade II, or
* LVEF \< 60%
* Stroke Volume Index \< 35 ml/m²
* Anatomically suitable for transfemoral TAVR using the Medtronic Evolut PRO+ or Evolut FX system
* The subject and the treating physician agree the subject will return for all required follow-up visits

Exclusion Criteria

* Age \< 65 years
* LVEF ≤ 20% by 2-D echo
* Class I indication for cardiac surgery
* Contraindication for placement of a bioprosthetic valve
* Documented history of cardiac amyloidosis
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medtronic Cardiovascular

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul Sorajja, MD

Role: PRINCIPAL_INVESTIGATOR

Allina Health System

Josep Rodes-Cabau, MD

Role: PRINCIPAL_INVESTIGATOR

Fondation IUCPQ

Stephan Windecker, Prof.

Role: PRINCIPAL_INVESTIGATOR

Inselspital, Universitätsspital Bern

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama at Birmingham (UAB) Hospital

Birmingham, Alabama, United States

Site Status

Abrazo Arizone Heart Hospital

Phoenix, Arizona, United States

Site Status

HonorHealth Scottsdale Shea Medical Center

Scottsdale, Arizona, United States

Site Status

Los Robles Hospital & Medical Center

Thousand Oaks, California, United States

Site Status

University of Colorado Hospital

Aurora, Colorado, United States

Site Status

Saint Vincents Medical Center

Bridgeport, Connecticut, United States

Site Status

Hartford Hospital

Hartford, Connecticut, United States

Site Status

MedStar Washington Hospital Center

Washington D.C., District of Columbia, United States

Site Status

Morton Plant Hospital

Clearwater, Florida, United States

Site Status

University of Florida

Gainesville, Florida, United States

Site Status

Saint Vincent's Medical Center Riverside

Jacksonville, Florida, United States

Site Status

Orlando Health

Orlando, Florida, United States

Site Status

Tallahassee Memorial Hospital

Tallahassee, Florida, United States

Site Status

Tampa General Hospital

Tampa, Florida, United States

Site Status

Jewish Hospital

Louisville, Kentucky, United States

Site Status

Terrebonne General Medical Center

Houma, Louisiana, United States

Site Status

The Johns Hopkins Hospital

Baltimore, Maryland, United States

Site Status

Tufts Medical Center

Boston, Massachusetts, United States

Site Status

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

Site Status

Baystate Medical Center

Springfield, Massachusetts, United States

Site Status

University of Michigan Health System - University Hospital

Ann Arbor, Michigan, United States

Site Status

Ascension Saint John Hospital

Detroit, Michigan, United States

Site Status

Spectrum Health

Grand Rapids, Michigan, United States

Site Status

Abbott Northwestern Hospital

Minneapolis, Minnesota, United States

Site Status

Mayo Clinic

Rochester, Minnesota, United States

Site Status

SSM Health Saint Louis University Hospital

St Louis, Missouri, United States

Site Status

Catholic Medical Center

Manchester, New Hampshire, United States

Site Status

Deborah Heart and Lung Center

Browns Mills, New Jersey, United States

Site Status

Englewood Hospital & Medical Center

Englewood, New Jersey, United States

Site Status

Northwell Health

Manhasset, New York, United States

Site Status

The Mount Sinai Hospital

New York, New York, United States

Site Status

Mission Hospital

Asheville, North Carolina, United States

Site Status

Wake Forest University Heatlh Sciences

Winston-Salem, North Carolina, United States

Site Status

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States

Site Status

Cleveland Clinic

Cleveland, Ohio, United States

Site Status

The Ohio State University Wexner Medical Center

Columbus, Ohio, United States

Site Status

Kettering Health Main Campus

Kettering, Ohio, United States

Site Status

Oregon Health & Science University Hospital

Portland, Oregon, United States

Site Status

Lehigh Valley Hospital, Inc

Allentown, Pennsylvania, United States

Site Status

UPMC Pinnacle Harrisburg Campus

Harrisburg, Pennsylvania, United States

Site Status

Monument Health Rapid City Hospital

Rapid City, South Dakota, United States

Site Status

Erlanger Medical Center

Chattanooga, Tennessee, United States

Site Status

Medical City Dallas

Dallas, Texas, United States

Site Status

Texas Health Harris Methodist Hospital Fort Worth

Fort Worth, Texas, United States

Site Status

Houston Methodist Hospital

Houston, Texas, United States

Site Status

Methodist Hospital San Antonio

San Antonio, Texas, United States

Site Status

Intermountain Cardiovascular and Thoracic Surgery

Salt Lake City, Utah, United States

Site Status

The University of Vermont

Burlington, Vermont, United States

Site Status

Carilion Roanoke Memorial Hospital

Roanoke, Virginia, United States

Site Status

Providence Sacred Heart Medical Center & Children's Hospital

Spokane, Washington, United States

Site Status

West Virginia University

Morgantown, West Virginia, United States

Site Status

Aurora Saint Lukes Medical Center

Milwaukee, Wisconsin, United States

Site Status

The Alfred Hospital

Melbourne, Victoria, Australia

Site Status

Fiona Stanley Hospital

Murdoch, , Australia

Site Status

University Hospital Sankt Poelten

Sankt Pölten, , Austria

Site Status

Allgemeines Krankenhaus - Universitätskliniken Wien

Vienna, , Austria

Site Status

CHU de Liege- Hopital du Sart Tilman

Liège, , Belgium

Site Status

Sunnybrook Health Sciences Centre

Toronto, Ontario, Canada

Site Status

Montreal Heart Hospital

Montreal, Quebec, Canada

Site Status

Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ)

Québec, Quebec, Canada

Site Status

Queen Elizabeth II Health Sciences Centre

Halifax, , Canada

Site Status

CHU de Rennes - Hôpital Pontchaillou

Rennes, Brittany Region, France

Site Status

CHRU Brest - Hôpital de la Cavale Blanche

Brest, , France

Site Status

Institut Mutualiste Montsouris

Paris, , France

Site Status

Hôpital Européen Georges Pompidou

Paris, , France

Site Status

Universitäts-Herzzentrum Freiburg - Bad Krozingen

Bad Krozingen, , Germany

Site Status

Universitätsklinikum Bonn

Bonn, , Germany

Site Status

Kath Saint Johannes-Gesellschaft Dortmund gGmbH Saint Johannes-Hospital Dortmund

Dortmund, , Germany

Site Status

Herzzentrum Leipzig GmbH

Leipzig, , Germany

Site Status

Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Mainz, , Germany

Site Status

Klinikum der Universität München - Campus Grosshadern

München, , Germany

Site Status

Galway University Hospitals - University Hospital Galway (UHG)

Galway, , Ireland

Site Status

Shaare Zedek Medical Center

Jerusalem, , Israel

Site Status

Rabin Medical Center- Beilinson Hospital

Petah Tikva, , Israel

Site Status

Presidio Ospedaliero Gaspare Rodolico

Catania, , Italy

Site Status

Ospedale San Raffaele - Milano

Milan, , Italy

Site Status

IRCCS Policlinico San Donato

San Donato Milanese, , Italy

Site Status

Shonan Kamakura General Hospital

Kanagawa, Kamakura, Japan

Site Status

Tokai University Hospital

Isehara, Kanagawa, Japan

Site Status

Kawasaki Saiwai Hospital

Kawasaki, Kanagawa, Japan

Site Status

Osaka Keisatsu Hospital

Osaka, , Japan

Site Status

Osaka University Hospital

Osaka, , Japan

Site Status

Catharina Ziekenhuis

Eindhoven, , Netherlands

Site Status

Universitair Medisch Centrum Groningen

Groningen, , Netherlands

Site Status

St Antonius Ziekenhuis

Nieuwegein, , Netherlands

Site Status

Erasmus MC

Rotterdam, , Netherlands

Site Status

Hospital Universitari Clínic de Barcelona

Barcelona, , Spain

Site Status

Hospital Universitario Ramón y Cajal

Madrid, , Spain

Site Status

Complejo Asistencial Universitario de Salamanca

Salamanca, , Spain

Site Status

Hospital Clínico Universitario de Valladolid

Valladolid, , Spain

Site Status

Skanes Universitetssjukhus

Lund, , Sweden

Site Status

Inselspital - Universitätsspital Bern

Bern, , Switzerland

Site Status

Saint Bartholomew's Hospital

London, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Austria Belgium Canada France Germany Ireland Israel Italy Japan Netherlands Spain Sweden Switzerland United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

D00411092

Identifier Type: -

Identifier Source: org_study_id